Please login to the form below

Not currently logged in
Email:
Password:

GSK rewards UK charities

GlaxoSmithKline has awarded a total of £300,000 to charities in the UK working to improve health within local communities.

GlaxoSmithKline (GSK) has awarded a total of £300,000 to charities in the UK working to improve health within local communities.

During the annual GSK Impact Awards, organised in partnership with independent charity, the Kingís Fund, 20 different UK-based charity groups were recognised for their contribution to healthcare improvement. Over a period of 11 years, GSK has donated over £2m to 220 healthcare charities throughout the nation.

Sir Christopher Gent, chairman of GSK, said: "We hope the GSK Impact Awards will help raise awareness of the excellent work these charities are doing, and the importance of such organisations in ensuring the good health of people across the UK."

Gent explained that the Impact Awards aim to provide financial assistance and recognition for charity groups in the UK working to improve health in local communities. The organisations honoured at the ceremony often suffer from a lack of resources, money and support despite tackling issues in a broad range of disease and healthcare areas.

The top 10 charities received individual prizes of £25,000 with five highly commended groups being awarded £5,000 and five runners up being granted £3,000.

Derby charity, Womenís Work, was named the winner of the event receiving an additional £10,000 on top of the award bestowed for being one of the top 10 groups. The group provides support to women being subjected to substance abuse and working in the street sex industry.

Dionne Reid, project manager at Womenís Work, said: "Winning the GSK Impact Award will help us continue our work and extend beyond the 300 women we have already reached since we set the charity up five years ago."

"This award brings untold benefits to Womenís Work. It gives us national recognition for the work we do in a difficult and stigmatised section of society," Reid concluded.

30th April 2008

Share

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Syneos Health™

Syneos Health™ is the only fully integrated biopharmaceutical solutions organization. Our company, including a Contract Research Organization (CRO) and Contract...

Latest intelligence

Is China ready for a pharmaceutical gold rush?
Some describe doing business in China as akin to the 1990s internet boom – so how stable is its future?...
AstraZeneca’s oncology renaissance
Susan Galbraith played a key role in restoring AstraZeneca’s place in cancer drug development – she talks about the future of oncology and why there’s more to be done to...
Navigating the antibiotic resistance crisis
Blue Latitude Health speaks to Tara DeBoer, PhD, Postdoctoral Researcher and CEO of BioAmp Diagnostics to explore the antimicrobial resistance crisis, and learn how a simple tool could support physicians...

Infographics